Australian Bioxyne Limited has signed a manufacturing agreement with global medical cannabis company Aurora Cannabis Inc., marking a significant step in its international expansion.
The deal, executed through Bioxyne’s wholly owned subsidiary Breathe Life Sciences (BLS), covers the production of pharmaceutical-grade medicinal cannabis products for supply into key markets.
The initial agreement includes the supply of GMP-certified medicinal cannabis oils into the Australian market, with deliveries already completed. The partnership is also expanding to include GMP-manufactured cannabis vapes for distribution across Australia, the United Kingdom and Germany, with onboarding for additional product lines now underway.
The collaboration reflects Bioxyne’s evolution from a domestic manufacturer to a global supplier capable of meeting the demands of highly regulated pharmaceutical environments. It also reinforces the company’s position in precision-dosed cannabis formats and scalable production.
“This partnership with Aurora represents a significant milestone for BLS as we expand our manufacturing capabilities. We are excited about the potential of our broader product portfolio across multiple international markets. This agreement validates our pharmaceutical manufacturing expertise and positions us well for growth,” said chief executive officer Sam Watson.
Aurora’s executive vice president, operations and supply chain, Alex Miller, said the agreement strengthens the company’s global supply chain. “As a global leader in medical cannabis, we’re focused on building a resilient, high-quality supply chain across key international markets. BLS brings strong GMP-manufacturing capabilities that complement our scale, regulatory scrutiny and commitment to delivering high quality medical cannabis products to patients.”
The companies have agreed to expand the scope of the agreement, including the production and distribution of a large quantity of vape products. Discussions are also progressing around additional product lines for Australia, the UK and Germany, further broadening BLS’s manufacturing footprint and market reach.
Article by Manufacturer’s Monthly: https://www.manmonthly.com.au/bioxyne-partners-with-aurora-cannabis/